Cover
Cover | May 14, 2024 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | May 14, 2024 |
Entity File Number | 001-40101 |
Entity Registrant Name | BRIACELL THERAPEUTICS CORP. |
Entity Central Index Key | 0001610820 |
Entity Tax Identification Number | 47-1099599 |
Entity Incorporation, State or Country Code | A1 |
Entity Address, Address Line One | Suite 300 - 235 15th Street |
Entity Address, City or Town | West Vancouver |
Entity Address, State or Province | BC |
Entity Address, Postal Zip Code | V7T 2X1 |
City Area Code | (604) |
Local Phone Number | 921-1810 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Common Shares, no par value | |
Title of 12(b) Security | Common Shares, no par value |
Trading Symbol | BCTX |
Security Exchange Name | NASDAQ |
Warrants to purchase common shares, no par value | |
Title of 12(b) Security | Warrants to purchase common shares, no par value |
Trading Symbol | BCTXW |